Genetic Engineering Plant Genomics Market Report 2026

The genetic engineering plant genomics market size has grown rapidly in recent years. It will grow from $46.41 billion in 2025 to $53.65 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to advancements in plant biotechnology research, increasing demand for higher crop yields, expansion of genetically modified crop cultivation, improvements in sequencing technologies, growing public and private research funding.

The genetic engineering plant genomics market size is expected to see rapid growth in the next few years. It will grow to $90 billion in 2030 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to increasing adoption of precision breeding techniques, rising focus on climate-resilient crops, expansion of genome editing regulatory approvals, growing investments in sustainable agriculture technologies, increasing demand for resource-efficient crop traits. Major trends in the forecast period include increasing adoption of crispr-based genome editing in crops, rising focus on abiotic stress tolerant plant varieties, growing integration of genomic data analytics, expansion of trait-specific crop development, enhanced emphasis on sustainable crop improvement.

The growing concerns over food security are expected to drive the growth of the genetic engineering plant genomics market in the coming years. Food security refers to the condition in which all individuals have reliable access to sufficient, safe, and nutritious food to maintain a healthy and active life. These concerns are driven by factors such as climate change, economic instability, and an increasing global population, which threaten food availability and accessibility. Genetic engineering in plant genomics contributes to food security by developing crops that are more resistant to pests, diseases, and environmental stresses, thereby improving agricultural productivity and stabilizing food supply. For example, in January 2025, the US Department of Agriculture, a US government agency responsible for food security statistics, reported that 13.5 percent of US households, or 18 million households, experienced food insecurity at some point during 2023, compared with 12.8 percent, or 17 million households, in 2022. Consequently, rising concerns about food security are expected to fuel the growth of the genetic engineering plant genomics market.

Leading companies in the genetic engineering plant genomics market are focusing on technological advancements, such as automated molecular breeding genotyping solutions, to improve precision and efficiency in crop breeding. An automated molecular breeding genotyping solution is a system that processes large volumes of plant samples accurately and efficiently using computerized technologies and software, streamlining genetic analysis for breeding programs. For instance, in June 2024, MGI Tech, a China-based biotechnology company, launched a comprehensive workflow solution for large-scale low-pass whole genome sequencing in agriculture. The solution includes an automated full-process product portfolio for molecular breeding and genotyping of agricultural diploid species. Enhanced by MGI’s automation platforms, the low-pass WGS solution overcomes conventional library preparation limitations by enabling ultra-high throughput with minimal tools, allowing rapid and cost-effective large-scale library preparation. It supports high throughput with the DNBSEQ-T7 sequencer and medium throughput with the DNBSEQ-G400 benchtop sequencer, making it ideal for agricultural genomics research.

In March 2024, GDM Seeds Inc., an Argentina-based agricultural solutions provider, acquired the Corn and Sorghum Business from KWS SAAT SE & Co. KGaA for an undisclosed amount. The acquisition aims to strengthen its seed development capabilities and expand its market presence in agricultural biotechnology across the region. It includes KWS’ entire South American corn breeding and sales operations, as well as production facilities for corn and sorghum in Brazil and Argentina. KWS SAAT SE & Co. KGaA is a Germany-based plant breeding company specializing in plant genomics and developing seeds for a variety of crops.

Major companies operating in the genetic engineering plant genomics market are BASF SE, Bayer AG, Thermo Fisher Scientific Inc., Suntory Holdings Limited, Corteva Inc., DuPont de Nemours Inc, Eurofins Scientific SE, Agilent Technologies Inc, ADAMA Ltd, Illumina Inc, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Zhejiang Xinan Chemical Industrial Group Co Ltd, UPL Limited, Qiagen N.V., Novogene Co Ltd, KWS SAAT SE & Co KGaA, Vilmorin & Cie, Neogen Corporation, Rubicon Genomics Inc, Verdesian Life Sciences LLC, GeneWiz Inc, Genotypic Technology Pvt Ltd, Syngenta AG, Keygene NV.

Asia-Pacific was the largest region in the genetic engineering plant genomics market in 2025. The regions covered in the genetic engineering plant genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the genetic engineering plant genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the genetic engineering plant genomics market by increasing costs of imported sequencing equipment, laboratory instruments, bioinformatics hardware, and specialized reagents used in genomic research and crop development. Research institutions and agribiotech firms in north america and europe are most affected due to reliance on imported high-end equipment, while asia-pacific faces higher costs in genomics service exports. These tariffs are elevating research expenditures and slowing project timelines. However, they are also supporting domestic biotech manufacturing, regional genomics infrastructure development, and local innovation ecosystems.

The genetic engineering plant genomics market research report is one of a series of new reports that provides genetic engineering plant genomics market statistics, including genetic engineering plant genomics industry global market size, regional shares, competitors with a genetic engineering plant genomics market share, detailed genetic engineering plant genomics market segments, market trends and opportunities, and any further data you may need to thrive in the genetic engineering plant genomics industry. This genetic engineering plant genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genetic engineering in plants involves modifying their genetic material to introduce or alter specific traits, while plant genomics studies the complete genetic composition of plants, including genes and DNA sequences, to understand their functions and interactions. These approaches enhance crop traits, improve agricultural productivity, and support sustainable farming practices.

The main types of genetic engineering in plant genomics include molecular engineering, genetic engineering, genome editing, and others. Molecular engineering in plant genomics focuses on modifying genetic material at the molecular level to enhance traits such as growth rate or nutrient absorption efficiency, using advanced techniques to precisely alter plant genes. These traits are categorized into yield improvement, disease resistance, herbicide tolerance, insect resistance, and abiotic stress tolerance, with applications across cereals and grains, oilseeds and pulses, fruits and vegetables, sugar crops, ornamentals, and alfalfa.

The genetic engineering plant genomics market consists of revenues earned by entities by providing services such as genetic modification of crops, genome sequencing and analysis, trait identification and enhancement, molecular breeding, and bioinformatics tools for agricultural and biotechnological applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The genetic engineering plant genomics market also includes sales of genetically modified seeds, biotechnological enzymes, proteins derived from genetically engineered plants, and diagnostic kits for genetic testing in agriculture. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.